Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treanda in previously treated multiple myeloma
NCT02315157Phase 1Withdrawn
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2014
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of bendamustine in multiple myeloma (MM) and plasma cell leukemia (PCL), sponsored by Sidney Kimmel Comprehensive Cancer Center. Planned start Jun 2014; status: withdrawn.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)plasma cell leukemia (PCL)
Beyond the preview
Go deeper on NCT02315157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315157.